{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:18:25Z","timestamp":1767853105473,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04509-7","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:36:33Z","timestamp":1764660993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A prognostic model for uveal melanoma in Asian populations: a comparative analysis of clinical features and gene expression patterns using the TRACE and TCGA data"],"prefix":"10.1186","volume":"26","author":[{"given":"Jingting","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingying","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangxu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"1","key":"4509_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, Carvajal RD, Belfort RN, Jia R, Shields JA, et al. Uveal melanoma. Nat Rev Dis Primers. 2020;6(1):24.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"4509_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/ajcp\/aqad029","volume":"160","author":"VT Gill","year":"2023","unstructured":"Gill VT, Norrman E, Sabazade S, Karim A, Lardner E, St\u00e5lhammar G. Multiorgan involvement of dormant uveal melanoma micrometastases in postmortem tissue from patients without coexisting macrometastases. Am J Clin Pathol. 2023;160(2):164\u201374.","journal-title":"Am J Clin Pathol"},{"issue":"24","key":"4509_CR3","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1056\/NEJMoa2304753","volume":"389","author":"JC Hassel","year":"2023","unstructured":"Hassel JC, Piperno-Neumann S, Rutkowski P, Baurain JF, Schlaak M, Butler MO, Sullivan RJ, Dummer R, Kirkwood JM, Orloff M, et al. Three-year overall survival with tebentafusp in metastatic uveal melanoma. N Engl J Med. 2023;389(24):2256\u201366.","journal-title":"N Engl J Med"},{"issue":"8","key":"4509_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/14712598.2022.2031970","volume":"22","author":"AW Liu","year":"2022","unstructured":"Liu AW, Wei AZ, Maniar AB, Carvajal RD. Tebentafusp in advanced uveal melanoma: proof of principle for the efficacy of T-cell receptor therapeutics and bispecifics in solid tumors. Expert Opin Biol Ther. 2022;22(8):997\u20131004.","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"4509_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","volume":"20","author":"RD Carvajal","year":"2023","unstructured":"Carvajal RD, Sacco JJ, Jager MJ, Eschelman DJ, Olofsson Bagge R, Harbour JW, Chieng ND, Patel SP, Joshua AM, Piperno-Neumann S. Advances in the clinical management of uveal melanoma. Nat Rev Clin Oncol. 2023;20(2):99\u2013115.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"4509_CR6","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/cncr.20866","volume":"103","author":"CC McLaughlin","year":"2005","unstructured":"McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103(5):1000\u201307.","journal-title":"Cancer"},{"issue":"4","key":"4509_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ajo.2005.05.034","volume":"140","author":"DN Hu","year":"2005","unstructured":"Hu DN, Yu GP, McCormick SA, Schneider S, Finger PT. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol. 2005;140(4):612\u201317.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"4509_CR8","doi-asserted-by":"publisher","first-page":"e109699","DOI":"10.1371\/journal.pone.0109699","volume":"9","author":"X Xu","year":"2014","unstructured":"Xu X, Wei WB, Li B, Gao F, Zhang Z, Jonas JB. Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese. PLoS One. 2014;9(10):e109699.","journal-title":"PLoS One"},{"key":"4509_CR9","doi-asserted-by":"crossref","unstructured":"Bakhoum MF, Esmaeli B. Molecular characteristics of uveal melanoma: insights from the Cancer Genome Atlas (TCGA) project. Cancers (Basel). 2019;11(8).","DOI":"10.3390\/cancers11081061"},{"issue":"4","key":"4509_CR10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s12253-017-0371-7","volume":"25","author":"B Schneider","year":"2019","unstructured":"Schneider B, Riedel K, Zhivov A, Huehns M, Zettl H, Guthoff RF, J\u00fcnemann A, Erbersdobler A, Zimpfer A. Frequent and yet unreported GNAQ and GNA11 mutations are found in uveal melanomas. Pathol Oncol Res. 2019;25(4):1319\u201325.","journal-title":"Pathol. Oncol. Res"},{"issue":"5","key":"4509_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/bjo.2009.174417","volume":"95","author":"H P\u00f3pulo","year":"2011","unstructured":"P\u00f3pulo H, Vinagre J, Lopes JM, Soares P. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas. Br J Ophthalmol. 2011;95(5):715\u201319.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"4509_CR12","doi-asserted-by":"publisher","first-page":"e1077","DOI":"10.1111\/aos.14760","volume":"99","author":"P Silva-Rodr\u00edguez","year":"2021","unstructured":"Silva-Rodr\u00edguez P, Bande M, Fern\u00e1ndez-D\u00edaz D, Lago-Baameiro N, Pardo M, Jos\u00e9 Blanco-Teijeiro M, Dom\u00ednguez F, Loidi L, Pi\u00f1eiro A. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort. Acta Ophthalmol. 2021;99(7):e1077\u201389.","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"4509_CR13","first-page":"5719","volume":"37","author":"F Psinakis","year":"2017","unstructured":"Psinakis F, Katseli A, Koutsandrea C, Frangia K, Florentin L, Apostolopoulou D, Dimakopoulou K, Papakonstantinou D, Georgopoulou E, Brouzas D. Uveal melanoma: GNAQ and GNA11 mutations in a Greek population. Anticancer Res. 2017;37(10):5719\u201326.","journal-title":"Anticancer Res"},{"issue":"4","key":"4509_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ophtha.2021.11.011","volume":"129","author":"APA Wierenga","year":"2022","unstructured":"Wierenga APA, Brouwer NJ, Gelmi MC, Verdijk RM, Stern MH, Bas Z, Malkani K, van Duinen SG, Ganguly A, Kroes WGM, et al. Chromosome 3 and 8q aberrations in uveal melanoma show greater impact on survival in patients with light iris versus dark iris color. Ophthalmology. 2022;129(4):421\u201330.","journal-title":"Ophthalmology"},{"issue":"6009","key":"4509_CR15","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330(6009):1410\u201313.","journal-title":"Science"},{"issue":"6","key":"4509_CR16","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.ophtha.2015.01.026","volume":"122","author":"CL Shields","year":"2015","unstructured":"Shields CL, Kaliki S, Furuta M, Fulco E, Alarcon C, Shields JA. American joint committee on cancer classification of uveal melanoma (anatomic stage) predicts prognosis in 7,731 patients: the 2013 Zimmerman Lecture. Ophthalmology. 2015;122(6):1180\u201386.","journal-title":"Ophthalmology"},{"issue":"2","key":"4509_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","volume":"32","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, et al. Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell. 2017;32(2):204\u201320.e215.","journal-title":"Cancer Cell"},{"issue":"28","key":"4509_CR18","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1200\/JCO.24.00447","volume":"42","author":"JW Harbour","year":"2024","unstructured":"Harbour JW, Correa ZM, Schefler AC, Mruthyunjaya P, Materin MA, Ta A, Skalet AH, Reichstein DA, Weis E, Kim IK, et al. 15-Gene expression profile and prame as integrated prognostic test for uveal melanoma: first report of collaborative ocular oncology group study No.2 (COOG2.1). J Clin Oncol. 2024;42(28):3319\u201329.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4509_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/CMR.0000000000000971","volume":"34","author":"D Suwajanakorn","year":"2024","unstructured":"Suwajanakorn D, Lane AM, Go AK, Hartley CD, Oxenreiter M, Wu F, Gragoudas ES, Sullivan RJ, Montazeri K, Kim IK. Impact of gene expression profiling on diagnosis and survival after metastasis in patients with uveal melanoma. Melanoma Res. 2024;34(4):319\u201325.","journal-title":"Melanoma Res"},{"issue":"5","key":"4509_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284\u201387.","journal-title":"Omics"},{"issue":"D1","key":"4509_CR21","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al. String v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u2013d613.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4509_CR22","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"Suppl 4","key":"4509_CR23","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"issue":"1","key":"4509_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"issue":"5","key":"4509_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u201357.","journal-title":"Nat Methods"},{"key":"4509_CR26","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"4509_CR27","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6).","DOI":"10.1093\/bib\/bbab260"},{"issue":"4","key":"4509_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, et al. The immune landscape of cancer. Immunity. 2018;48(4):812\u201330.e814.","journal-title":"Immunity"},{"issue":"3","key":"4509_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/pcmr.13161","volume":"37","author":"XL Liu","year":"2024","unstructured":"Liu XL, Run-Hua Z, Pan JX, Li ZJ, Yu L, Li YL. Emerging therapeutic strategies for metastatic uveal melanoma: targeting driver mutations. Pigment Cell Melanoma Res. 2024;37(3):411\u201325.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"4509_CR30","first-page":"9","volume":"21","author":"P Katopodis","year":"2021","unstructured":"Katopodis P, Khalifa MS, Anikin V. Molecular characteristics of uveal melanoma and intraocular tumors. Oncol Lett. 2021;21(1):9.","journal-title":"Oncol Lett"},{"issue":"12","key":"4509_CR31","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/s41417-022-00443-8","volume":"29","author":"AZ Wei","year":"2022","unstructured":"Wei AZ, Maniar AB, Carvajal RD. New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma. Cancer Gene Ther. 2022;29(12):1819\u201326.","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"4509_CR32","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.18240\/ijo.2022.10.02","volume":"15","author":"S Kassumeh","year":"2022","unstructured":"Kassumeh S, Arrow S, Kafka A, Luft N, Priglinger SG, Wolf A, Eibl-Lindner K, Wertheimer CM. Pharmacological drug screening to inhibit uveal melanoma metastatic cells either via EGF-R, MAPK, mTOR or PI3K. Int J Ophthalmol. 2022;15(10):1569\u201376.","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"4509_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41389-024-00511-8","volume":"13","author":"JJ Park","year":"2024","unstructured":"Park JJ, Hamad SA, Stewart A, Carlino MS, Lim SY, Rizos H. PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma. Oncogenesis. 2024;13(1):9.","journal-title":"Oncogenesis"},{"key":"4509_CR34","doi-asserted-by":"publisher","first-page":"1610980","DOI":"10.3389\/pore.2023.1610980","volume":"29","author":"Y Li","year":"2023","unstructured":"Li Y, Xiong C, Wu LL, Zhang BY, Wu S, Chen YF, Xu QH, Liao HF. Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma. Pathol Oncol Res. 2023;29:1610980.","journal-title":"Pathol. Oncol. Res"},{"issue":"1","key":"4509_CR35","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1186\/s12885-021-08788-3","volume":"21","author":"T Wang","year":"2021","unstructured":"Wang T, Zhang Y, Bai J, Xue Y, Peng Q. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma. BMC Cancer. 2021;21(1):1068.","journal-title":"BMC Cancer"},{"issue":"8","key":"4509_CR36","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1167\/iovs.14-14394","volume":"55","author":"T Jehs","year":"2014","unstructured":"Jehs T, Faber C, Juel HB, Bronkhorst IH, Jager MJ, Nissen MH. Inflammation-induced chemokine expression in uveal melanoma cell lines stimulates monocyte chemotaxis. Invest Ophthalmol Vis Sci. 2014;55(8):5169\u201375.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"4509_CR37","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1167\/iovs.02-0624","volume":"44","author":"R Clarijs","year":"2003","unstructured":"Clarijs R, Schalkwijk L, Ruiter DJ, de Waal Rm. EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44(5):1801\u201306.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4509_CR38","doi-asserted-by":"crossref","unstructured":"Qin Y, Bollin K, de Macedo MP, Carapeto F, Kim KB, Roszik J, Wani KM, Reuben A, Reddy ST, Williams MD, et al. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. J Immunother Cancer. 2020;8(2).","DOI":"10.1136\/jitc-2020-000960"},{"issue":"5","key":"4509_CR39","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00262-020-02773-8","volume":"70","author":"L Singh","year":"2021","unstructured":"Singh L, Singh MK, Kenney MC, Jager MJ, Rizvi MA, Meel R, Lomi N, Bakhshi S, Sen S, Kashyap S. Prognostic significance of PD-1\/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters. Cancer Immunol Immunother. 2021;70(5):1291\u2013303.","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"4509_CR40","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1167\/iovs.04-0599","volume":"45","author":"YG He","year":"2004","unstructured":"He YG, Mayhew E, Mellon J, Niederkorn JY. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells. Invest Ophthalmol Vis Sci. 2004;45(12):4240\u201346.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4509_CR41","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4049\/jimmunol.165.2.710","volume":"165","author":"AC Repp","year":"2000","unstructured":"Repp AC, Mayhew ES, Apte S, Niederkorn JY. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by nk cells. The J Immunol. 2000;165(2):710\u201315.","journal-title":"The J Immunol"},{"key":"4509_CR42","doi-asserted-by":"crossref","unstructured":"Hoefsmit EP, Rozeman EA, Van TM, Dimitriadis P, Krijgsman O, Conway JW, Pires da Silva I, van der Wal JE, Ketelaars SLC, Bresser K, et al. Comprehensive analysis of cutaneous and uveal melanoma liver metastases. J Immunother Cancer. 2020;8(2).","DOI":"10.1136\/jitc-2020-001501"},{"issue":"3","key":"4509_CR43","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.18632\/oncotarget.6500","volume":"7","author":"H Yang","year":"2016","unstructured":"Yang H, Brackett CM, Morales-Tirado VM, Li Z, Zhang Q, Wilson MW, Benjamin C, Harris W, Waller EK, Gudkov AV, et al. The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an nk cell-dependent mechanism. Oncotarget. 2016;7(3):2936\u201350.","journal-title":"Oncotarget"},{"key":"4509_CR44","doi-asserted-by":"publisher","first-page":"666462","DOI":"10.3389\/fcell.2021.666462","volume":"9","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Su J, Li L, Du W. Identification of precise therapeutic targets and characteristic prognostic genes based on immune gene characteristics in uveal melanoma. Front Cell Dev Biol. 2021;9:666462.","journal-title":"Front. Cell Dev. Biol"},{"issue":"8","key":"4509_CR45","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","volume":"119","author":"MD Onken","year":"2012","unstructured":"Onken MD, Worley LA, Char DH, Augsburger JJ, Correa ZM, Nudleman E, Tm A, Altaweel MM, Bardenstein DS, Finger PT, et al. Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology. 2012;119(8):1596\u2013603.","journal-title":"Ophthalmology"},{"issue":"3","key":"4509_CR46","doi-asserted-by":"publisher","first-page":"Mmt62","DOI":"10.2217\/mmt-2022-0003","volume":"9","author":"W Bk","year":"2022","unstructured":"Bk W, Siegel JJ, Alsina KM, Johnston L, Sisco A, LiPira K, Selig SM, Hovland PG. Uveal melanoma patient attitudes towards prognostic testing using gene expression profiling. Melanoma Manag. 2022;9(3):Mmt62.","journal-title":"Melanoma Manag"},{"issue":"5","key":"4509_CR47","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000508382","volume":"6","author":"TM Aaberg","year":"2020","unstructured":"Aaberg TM, Covington KR, Tsai T, Shildkrot Y, Plasseraud KM, Alsina KM, Oelschlager KM, Monzon FA. Gene expression profiling in Uveal melanoma: five-year prospective outcomes and meta-analysis. Ocul Oncol Pathol. 2020;6(5):360\u201367.","journal-title":"Ocul Oncol Pathol"},{"key":"4509_CR48","doi-asserted-by":"publisher","first-page":"1138452","DOI":"10.3389\/fphar.2023.1138452","volume":"14","author":"S Meng","year":"2023","unstructured":"Meng S, Zhu T, Fan Z, Cheng Y, Dong Y, Wang F, Wang X, Dong D, Yuan S, Zhao X. Integrated single-cell and transcriptome sequencing analyses develops a metastasis-based risk score system for prognosis and immunotherapy response in uveal melanoma. Front Pharmacol. 2023;14:1138452.","journal-title":"Front Pharmacol"},{"key":"4509_CR49","doi-asserted-by":"publisher","first-page":"1198944","DOI":"10.3389\/fendo.2023.1198944","volume":"14","author":"X Song","year":"2023","unstructured":"Song X, Na R, Peng N, Cao W, Ke Y. Exploring the role of macrophages in the progression from atypical hyperplasia to endometrial carcinoma through single-cell transcriptomics and bulk transcriptomics analysis. Front Endocrinol (Lausanne). 2023;14:1198944.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"13","key":"4509_CR50","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1167\/iovs.18-26477","volume":"60","author":"Q Hou","year":"2019","unstructured":"Hou Q, Han S, Yang L, Chen S, Chen J, Ma N, Wang C, Tang J, Chen X, Chen F, et al. The interplay of microRNA-34a, LGR4, EMT-associated factors, and MMP2 in regulating uveal melanoma cells. Invest Ophthalmol Vis Sci. 2019;60(13):4503\u201310.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"4509_CR51","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.exer.2008.03.010","volume":"86","author":"K Lai","year":"2008","unstructured":"Lai K, Conway RM, Crouch R, Jager MJ, Madigan MC. Expression and distribution of MMPs and TIMPs in human uveal melanoma. Exp Eye Res. 2008;86(6):936\u201341.","journal-title":"Exp Eye Res"},{"issue":"1","key":"4509_CR52","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s13046-018-0982-1","volume":"37","author":"S Rossi","year":"2018","unstructured":"Rossi S, Cordella M, Tabolacci C, Nassa G, D\u2019Arcangelo D, Senatore C, Pagnotto P, Magliozzi R, Salvati A, Weisz A, et al. TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness. J Exp Clin Cancer Res. 2018;37(1):326.","journal-title":"J Exp Clin Cancer Res"},{"issue":"18","key":"4509_CR53","doi-asserted-by":"publisher","first-page":"e70102","DOI":"10.1111\/jcmm.70102","volume":"28","author":"C Wang","year":"2024","unstructured":"Wang C, Zhao Y, Zhang S, Du M, He G, Tan S, Li H, Zhang D, Cheng L. Single-cell rna sequencing reveals the heterogeneity of MYH11+ tumour-associated fibroblasts between left-sided and right-sided colorectal cancer. J Cell Mol Med. 2024;28(18):e70102.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"4509_CR54","first-page":"3899","volume":"19","author":"MJ Nie","year":"2020","unstructured":"Nie MJ, Pan XT, Tao HY, Xu MJ, Liu SL, Sun W, Wu J, Zou X. Clinical and prognostic significance of MYH11 in lung cancer. Oncol Lett. 2020;19(6):3899\u2013906.","journal-title":"Oncol Lett"},{"issue":"11","key":"4509_CR55","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/exd.12548","volume":"23","author":"PM Amann","year":"2014","unstructured":"Amann PM, Czaja K, Bazhin AV, R\u00fchl R, Skazik C, Heise R, Marquardt Y, Eichm\u00fcller SB, Merk HF, Baron JM. Knockdown of lecithin retinol acyltransferase increases all-trans retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells. Exp Dermatol. 2014;23(11):832\u201337.","journal-title":"Exp Dermatol"},{"issue":"25","key":"4509_CR56","doi-asserted-by":"publisher","first-page":"21346","DOI":"10.1074\/jbc.M112.355834","volume":"287","author":"M Tarragona","year":"2012","unstructured":"Tarragona M, Pavlovic M, Arnal-Estap\u00e9 A, Urosevic J, Morales M, Guiu M, Planet E, Gonz\u00e1lez-Su\u00e1rez E, Gomis RR. Identification of nog as a specific breast cancer bone metastasis-supporting gene. J Biol Chem. 2012;287(25):21346\u201355.","journal-title":"J Biol Chem"},{"issue":"7","key":"4509_CR57","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/pca.3193","volume":"34","author":"LP Liu","year":"2023","unstructured":"Liu LP, Liu N, Zhang HN, Li D. Exploring and validating the metastasis mechanism of pathenolide interfering with cutaneous melanoma through er stress-dependent apoptosis based on the network pharmacology. Phytochem Anal. 2023;34(7):745\u201354.","journal-title":"Phytochem Anal"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04509-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04509-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04509-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:02:32Z","timestamp":1767834152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-025-04509-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4509"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04509-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adheres to the Helsinki Declaration and has received approval from the Ethics Committee of Beijing Tongren Hospital (Ethics Review Number: TRECKY2018-056). All patients signed informed consent for the use of tissue for research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}